• This topic is empty.
Viewing 0 reply threads
  • Author
    • #22049
      Kevin Schaefer

      Hey everyone! Hope you’re all having a great week so far.

      Check out the latest podcast episode here. In episode 50, Michael and I discuss updates on Roche and Genentech’s experimental therapy risdiplam. Now that this drug is under FDA-approval, we answer questions regarding its potential cost, and what kind of impact it will have on the SMA community. 

      We also talk about two of our recent columns from our main site. The first is about media representation of people with disabilities; and the second, written by parent columnist Michael Casten, is about working through life’s frustrations. Listen here, and share your thoughts in our forums.


      Hope you all enjoy! For more conversations and interviews, check out the podcast archives here.

      Do you have any takeaways from this episode? Do you have any questions regarding risdiplam?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account

Verify you are not a robot